Bioactive peptides of animal origin: a review

Journal of Food Science and Technology

Volumn 52, Issue 9, 2015, Pages 5377-5392

  Bhat, Z F ^a   Kumar, Sunil ^a   Bhat, Hina Fayaz ^b  

^a SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF JAMMU   (India)

^b SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF KASHMIR   (India)

Author keywords

Animal origin; Bioactive peptides; Bioactivities; Production

Indexed keywords

ANIMALS; BIOACTIVITY; BIOCHEMISTRY; BLOOD PRESSURE; FUNCTIONAL FOOD; HEALTH; PEPTIDES; PRODUCTION;

ANTI-MICROBIAL PROPERTIES; ANTI-OXIDANT ACTIVITIES; BIOACTIVE PEPTIDES; CHOLESTEROL LOWERING; FUNCTIONAL PRODUCTS; IMMUNOMODULATORY EFFECTS; MINERAL ABSORPTION; SCIENTIFIC SECTORS;

PROTEINS;

ANIMALIA;

EID: 84940453782     PISSN: 00221155     EISSN: 09758402     Source Type: Journal    
DOI: 10.1007/s13197-015-1731-5     Document Type: Review

References (177)

1. Agyei D, Danquah MK (2011) Industrial scale manufacturing of pharmaceutical grade bioactive peptides. Biotechnol Adv 29(3):272–277
2. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y (2005) Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high normal blood pressure or mild hypertension. J Am Coll Nutr 24(4):257–265
3. Akai S, Alizadeh-Pasdar N (2006) Rational designing of bioactive peptides. In: Mine V, Shahidi F (eds) Nutraceutical proteins and peptides in health and disease. Taylor and Francis, FL, p 565–582
4. Arihara K (2004) Functional foods. In: Jensen W, Devine C, Dikemann M (eds) Encyclopedia of meat sciences, vol 1. Elesevier Science, London, pp 492–499
5. Arihara K (2006) Strategies for designing novel functional meat products. Meat Sci 74:219–229
6. Arihara K, Nakashima Y, Mukai T, Ishikawa S, Itoh M (2001) Peptide inhibitors for angiotensin I-converting enzyme from enzymatic hydrolysates of porcine skeletal muscle proteins. Meat Sci 57:319–324
7. Bah CSF, Bekhit A, El-Din A, Carne A, McConnellc MA (2013) Slaughterhouse blood: an emerging source of bioactive compounds. Com Rev Food Sci Food Saf 12:314–331
8. Baldauf F, Belter J, Horn U, Krug M, Metzlaff M, Polley A (1994) In β-casomorphins and related peptides: recent developments. V Brantl and H Teschemacher Eds, VCH Veinheim, pp 73–80
9. Becker GL (1993) Preserving food and health: antioxidants make functional, nutritious preservatives. Food Process (Chicago) 12:54–56
10. Berrocal R, Chanton S, Juilleart MA, Pavillard B, Scherz JC, Jost R (1989) Tryptic phosphopeptides from whole casein. II Physicochemical properties related to the solubilization of calcium. Dairy Res 56:335–341
11. Chabance B, Marteau P, Rambaud JC, Migliore-Samour D, Jollès P, Boynard M, Perrotin P, Buillet R, Fiat AM (1998) Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 80:155–165
12. Chakrabarti S, Jahandideh F, Wu J (2014) Food-derived bioactive peptides on inflammation and oxidative stress. Biomed Res. doi:10.1155/2014/608979
13. Chen GW, Tsai JS, Sun Pan B (2007) Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease facilitated lactic fermentation. Int Dairy J 17:641–647
14. Chiang WE, Cordle CT, Thomas RL (1995) Casein hydrolysate produced using a formed-in-place membrane reactor. J Food Sci 60:1349–1352
15. Clare DA, Swaisgood HE (2000) Bioactive milk peptides: a prospectus. J Dairy Sci 83:1187–1195
16. Czapla MA, Champion HC, Zadina JE, Kastin AJ, Hackler L, Ge LJ, Kadowitz PJ (1998) Endomorphin 1 and 2, endogenous mu-opioid agonists, decrease systemic arterial pressure in the rat. Life Sci 62:PL175–PL179
17. Danquah MK, Agyei D (2012) Pharmaceutical applications of bioactive peptides. Biotechnol 1(2):5
18. Dave LA, Montoya CA, Rutherfurd SM, Moughan PJ (2014) Gastrointestinal endogenous proteins as a source of bioactive peptides - an In silico study. PLoS ONE 9(6):e98922
19. deCosta EL, Rocha Montijo JA, Netto FM (2007) Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates. Int Dairy J 17:632–640
20. Diplock AT, Aggett PJ, Ashwell M, Bornet F, Fern EB, Roberfroid MB (2000) Scientific concepts of functional foods in Europe: consensus document. In: Buttriss J, Saltmarsh M (eds) Functional foods II- claims and evidence. The Royal Society of Chemistry, Cambridge, p 8–59
21. Donkor O, Henriksson A, Vasiljevic T, Shah NP (2007) Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of growth and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk. Lait 86:21–38
22. Dziuba B, Dziuba M (2014) Milk proteins-derived bioactive peptides in dairy products: molecular, biological and methodological aspects. Acta Sci Pol Technol Aliment 13(1):5–25
23. Dziuba J, Iwaniak A (2006) Database of protein and bioactive peptide sequences. In: Mine V, Shahidi F (eds) Nutraceutical proteins and peptides in health and disease. Taylor and Francis, FL, p 543–563
24. Erdmann K, Cheung BWY, Schröder H (2008) The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J Nutr Biochem 19:643–654
25. Ferreira IMPLVO, Pinho O, Mota MV, Tavares P, Pereira A, Goncalves MP, Torres D, Rocha C, Teixeira JA (2007) Preparation of ingredients containing an ACE inhibitory peptide by tryptic hydrolysis of whey protein concentrates. Int Dairy J 17:481–487
26. Fiat AM, Miglilore-Samour D, Jollès P, Crouet L, Collier C, Caen J (1993) Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immuno-modulating activities. J Dairy Sci 76:301–310
27. FitzGerald R, Murray BA (2006) Bioactive peptides and lactic fermentations. Int J Dairy Technol 59:118–125
28. FitzGerald RJ, Murray BA, Walsh DJ (2004) Hypotensive peptides from milk proteins. J Nutr 134:980S–988S
29. Fuglsang A, Rattray FP, Nilsson D, Nyborg NCB (2003) Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo. Antonie Van Leeuwenhoek 83:27–34
30. Fu-yuan C, Yu-tse L, Tien-chun W, Liang-chuan L, Sakata R (2008) The development of angiotensin I-converting enzyme inhibitor derived from chicken bone protein. Anim Sci J 79:122–128
31. Gagnaire V, Pierre A, Molle D, Leonil J (1996) Phosphopeptides interacting with colloidal calcium phosphate isolated by tryptic hydrolysis of bovine casein micelles. J Dairy Res 63:405–422
32. Gauthier SF, Pouliot Y, Saint-Sauveur D (2006) Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. Int Dairy J 16:1315–1323
33. Gill I, López-Fandino R, Jorba X, Vulfson EN (1996) Biologically active peptides and enzymatic approaches to their production. Enzym Microb Technol 18:162–183
34. Girgih AT, Udenigwe CC, Hasan FM, Gill TA, Aluko RE (2013) Antioxidant properties of Salmon (Salmo salar) protein hydrolysate and peptide fractions isolated by reverse phase HPLC. Food Res Int 52(1):315–322
35. Gobbetti M, Minervini F, Rizzello CG (2004) Angiotensin I converting-enzyme-inhibitory and antimicrobial bioactive peptides. Int J Dairy Technol 57:172–188
36. Gobbetti M, Minervini F, Rizzello CG (2007) Bioactive peptides in dairy products. In: Hui YH (ed) Handbook of foodproducts manufacturing. Wiley, Hoboken, pp 489–517
37. Gomez-Ruiz JA, Ramos M, Recio I (2002) Angiotensin-converting-enzyme-inhibitory peptides in Manchengo cheeses manufactured with different starter cultures. Int Dairy J 12:697–706
38. Gómez-Ruiz JA, Ramos M, Recio I (2004) Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion. Int Dairy J 14:1075–1080
39. de Llano Gonzalez D, Sanchez CP (2003) Peptides. In: Caballero B, Trugo LC, Finglas PM (eds) Encyclopedia of food science and nutrition, 2nd edn. Acedemic Press, London, pp 4468–4473
40. Guesdon B, Pichon L, Tome D 2006. In: Y Mine, F Shahidi (Eds) Nutraceutical proteins and peptides in health and disease. Taylor and Francis Group, Boca Raton, pp 367–376.
41. Guha P, Kaptan E, Bandyopadhyaya G, Kaczanowska S, Davila E, Thompson K, Martin SS, Kalvakolanu DV, Vasta GR, Ahmed H (2013) Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis. Proc Natl Acad Sci. doi:10.1073/pnas.1202653110
42. Hajirostamloo B (2010) Bioactive component in milk and dairy product. World Acad Sci Eng Technol 72:162–166
43. Haque E, Chand R (2008) Antihypertensive and antimicrobial bioactive peptides from milk proteins. Eur Food Res Technol 227:7–15
44. Harada K, Maeda T, Hasegawa Y, Tokunaga T, Tamura Y, Koizumi T (2010) Antioxidant activity of fish sauces including puffer (Lagocephalus wheeleri) fish sauce measured by the oxygen radical absorbance capacity method. Mol Med Rep 3(4):663–668
45. Hartmann R, Gunther S, Martin D, Meisel H, Pentzien AK, Schlimme E, Scholz N (2000) Cytochemical model systems for the detectionand characterization of potentially bioactive milk components. Kiel Milchwirtschaftliche Forschungsberichte 52:61–85
46. Hata Y, Yamamoto M, Ohni H, Nakajima K, Nakamura Y, Takano T (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64:767–771
47. Hau J, Cazes D, Fay LB (1997) Comprehensive study of the beefy meaty peptide. J Agric Food Chem 45:1351–1355
48. Hipkiss AR, Brownson CA (2000) A possible new role for the antiageing peptide carnosine. Cell Mol Life Sci 57:747–753
49. Hirota T, Ohki K, Kawagishi R, Kajimoto Y, Mizuno S, Nakamura Y, Kitakaze M (2007) Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens Res 30:489–496
50. Host A, Halken S (2004) Hypoallergenic formulas-when, to whom and how long: after more than 15 years we know the right indication. Allergy 59:45–52
51. Hsu KC, Li-Chan ECY, Jao CL (2010) Antiproliferative activity of peptides prepared from enzymatic hydrolysates of tuna dark muscle on human breast cancer cell line MCF-7. Food Chem 126:617–622
52. Jang A, Jo C, Kang KS, Lee M (2008) Antimicrobial and human cancer cell cytotoxic effect of synthetic angiotensin-converting enzyme (ACE) inhibitory peptides. Food Chem 107:327–336
53. Jang A, Lee M (2005) Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates. Meat Sci 69:653–661
54. Jauhiainen T, Korpela R (2007) Milk peptides and blood pressure. J Nutr 137:825S–829S
55. Jauhiainen T, Vapaatalo H, Poussa T, Kyrönpalo S, Rasmussen M, Korpela R (2005) Lactobacillus helveticus fermented milk reduces blood pressure in 24-h ambulatory blood pressure measurement. Am J Hypertens 18:1600–1605
56. Johanna M (2007) Metalloproteases. In: Poaina J, MacCble AP (eds) Industrial enzymes, structure, function and applications. Springer Publisher, The Netherlands
57. Jollés P, Caen JP (1991) Parallels between milk clotting and blood clotting: opportunities for milk-derived products. Trends Food Sci Technol 2:42–43
58. Jollès P, Levy-Toledano S, Fiat AM, Soria C, Gillesen D, Thomaidis A, Dunn FW, Caen J (1986) Analogy between fibrinogen and casein: effect of an undecapeptide isolated from k-casein on platelet function. Eur J Biochem 158:379–382
59. Jung WK, Park PJ, Byun HG, Moon SH, Kim SK (2005) Preparation of Hoki (Johnius belengerii) bone oligophosphopeptide with a high affinity to calcium by carnivorous intestine crude proteinase. Food Chem 91:333–340
60. Kazunori K, Tomatsu M, Fuchu H, Sugiyama M, Kawahara S, Yamauchi K et al (2003) Purification and characterization of an angiotensin I-converting enzyme inhibitory peptide derived from porcine troponin C. Anim Sci J 74:53–58
61. Khora SS (2013) Marine fish-derived bioactive peptides and proteins for human therapeutics. Int J Pharm Pharm Sci 5:31–37
62. Kim SK, Byun HG, Park PJ, Shahidi F (2001) Angiotensin I converting enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate. J Agric Food Chem 49:2992–2997
63. Kitts DD, Weiler K (2003) Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr Pharm Des 9:1309–1323
64. Ko JY, Lee JH, Samarakoon K, Kim JS, Jeon YJ (2013) Purification and determination of two novel antioxidant peptides from flounder fish (Paralichthys olivaceus) using digestive proteases. Food Chem Toxicol 52:113–120
65. Korhonen H (2009) Milk-derived bioactive peptides: from science to applications. J Funct Foods 1:177–187
66. Korhonen H, Pihlanto A (2003a) Food-derived bioactive peptides-opportunities for designing future foods. Curr Pharm Des 9:1297–1308
67. Korhonen H, Pihlanto A (2003b) Bioactive peptides: novel applications for milk proteins. Appl Biotechnol Food Sci Policy 1:133–144
68. Korhonen H, Pihlanto A (2006) Bioactive peptides: production and functionality. Int Dairy J 16:945–960
69. Korhonen H, Pihlanto A (2007) Bioactive peptides from food proteins. In: Hui YH (ed) Handbook of food products manufacturing. Wiley, Hoboken, pp 5–37
70. Korpela R, Tossavainen O, Korhonen H, Vapaatalo H (2000) Alphalactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 66:1535–1543
71. Kovacs-Nolan J, Phillips M, Mine Y (2005) Advances in the value of eggs and egg components for human health. J Agric Food Chem 53:8421–8431
72. Lax R (2010) The future of peptide development in the pharmaceutical industry. Phar Manuf: Int Pept Rev. 2010. Retrieved 10th December, 2012, from http://www.polypeptide.com/assets/002/5188.pdf
73. Lee SH, Song KB (2009a) Purification of a calcium-binding peptide from hydrolysates of porcine blood plasma protein. J Korean Soc Appl Biol Chem 52:290–294
74. Lee SH, Song KB (2009b) Purification of an iron-binding nona-peptide from hydrolysates of porcine blood plasma protein. Process Biochem 44:378–381
75. Li-Chan ECY, Powrie WD, Nakai S (1995) The chemistry of eggs and egg products. In: Stadelman WJ, Cotterill OJ (eds) Egg Science and Technology, 4th Ed. Haworth Press, New York, p 105–175
76. Li G, Le G, Shi Y, Shrestha S (2004) Angiotensin I-convertingenzyme inhibitory peptides derived from food proteins andtheir physiological and pharmacological effects. Nutr Res 24:469–486
77. Li Y, Yu J (2014) Research progress in structure-activity relationship of bioactive peptides. J Med Food. doi:10.1089/jmf.2014.0028
78. López-Expósito I, Quiros A, Amigo L, Recio I (2007) Caseinhydrolysates as a source of antimicrobial, antioxydant andantihypertensive peptides. Lait 87:241–249
79. López-Expósito I, Recio I (2006) Antibacterial activity of peptides and folding variants from milk proteins. Int Dairy J 16:1294–1305
80. López-Fandino R, Recio I, Ramos M (2007) Egg-protein-derived peptides with antihypertensive activity. In: Huopalahti R, López-Fandiño R, Anton M, Schade R (eds) Bioactive egg compounds. Springer, Verlag, pp 199–209
81. Lynch PB, Kerry JP (2000) Utilizing diet to incorporate bioactive compounds and improve the nutritional quality of muscle foods. In: Decker E, Faustman C, Lopez-Bote CJ (eds) Antioxidants in muscle foods. Willey, New York, pp 455–480
82. Maehashi K, Matsuzaki M, Yamamoto Y, Udaki S (1999) Isolation of peptides from an enzymatic hydrolyzate of food proteins and characterization of their taste properties. Biosci Biotechnol Biochem 63:555–559
83. Maeno M, Yamamoto N, Takano T (1996) Identification of antihypertensivepeptides from casein hydrolysate produced by a proteinase from Lactobacillushelveticus CP790. J Dairy Sci 73:1316–1321
84. Maes W, van Camp J, Vermeirssen V, Hemeryck M, Ketelslegers JM, Schrezenmeier J, van Oostveldt P, Huyghebaert A (2004) Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1by endothelial cells. Regul Pept 118:105–109
85. Mannheim A, Cheryan M (1990) Continuous hydrolysis of milk protein in a membrane reactor. J Food Sci 55:381–385
86. Manso MA, López-Fandino R (2003) Angiotensin I convertingenzyme-inhibitory activity of bovine; ovine; and caprine kappa-casein macropeptides and their tryptic hydrolysates. J Food Prot 66:1686–1692
87. Martin-Orue C, Henry G, Bouhallab S (1999) Tryptic hydrolysis of k-caseinomacropeptide: control of the enzymatic reaction in acontinuous membrane reactor. Enzym Microbiol Technol 24:173–180
88. Masuda O, Nakamura Y, Takano T (1996) Antihypertensive peptides are present in aorta after oral administration of sourmilk containing these peptides to spontaneously hypertensive rats. J Nutr 126:3063–3068
89. Matar C, LeBlanc JG, Martin L, Perdigo´n G (2003) Biologicallyactive peptides released in fermented milk: role and functions. In: Farnworth ER (ed) Handbook of fermented functional foods, Functional foods and nutraceuticals series. CRC Press, Florida, pp 177–201
90. McDonagh D, FitzGerald RJ (1998) Production of caseinophosphopeptides (CPPs) from sodium caseinate using a range of commercial protease preparations. Int Dairy J 8:39–45
91. McDonald RS, Thornton WH, Marshall RT (1994) A cell culture model to identify biologically active peptides generated by bacterial hydrolysis of casein. J Dairy Sci 77:1167–1175
92. Meisel H (1997a) Biochemical properties of regulatory peptides derived from milk proteins. Biopolym 43:119–128
93. Meisel H (1997b) Biochemical properties of bioactive peptides derived from milk proteins: Potential nutraceuticals for food and pharmaceutical applications. Livest Prod Sci 50:125–138
94. Meisel H (1998) Overview on milk protein–derived peptides. Int Dairy J 8:363–373
95. Meisel H (2005) Biochemical properties of peptides encrypted in bovine milk proteins. Curr Med Chem 12:1905–1919
96. Meisel H, FitzGerald RJ (2003) Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des 9:1289–1295
97. Meisel H, Walsh DJ, Murray B, FitzGerald RJ (2006) ACE inhibitory peptides. In: Mine Y, Shahidi F (eds) Nutraceutical proteins and peptides in health and disease. Nutraceutical science and technology, vol 4. Taylor and Francis, Boca Raton, pp 269–315
98. Meister W, Birch-Hirschfeld E, Koban M, Schilken U, Kunze G, Blasig R (1994) β-casomorphins and related peptides. In: Brantl V, Teschemacher H (eds) Recent developments. VCH, Veinheim, pp 66–72
99. Mendis E, Rajapakse N, Kim S (2005) Antioxidant properties of a radical scavenging peptide purified from enzymatically prepared fish skin gelatine hydrolysate. J Agric Food Chem 53:581–587
100. Mils S, Ross RP, Hill C, Fitzgerald GF, Stanton C (2011) Milk intelligence: mining milk for bioactive substances associated with human heath. Int Dairy J 21:377–401
101. Mizushima S, Ohshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Y, Tochikubo O, Ueshima H (2004) Randomized controlled trial of sour milk on blood pressure inborderline hypertensive men. Am J Hypertens 17:701–706
102. Moller NP, Scholz-Ahrens KE, Roos N, Schrezenmeir J (2008) Bioactive peptidesand proteins from foods: indication for health effects. Eur J Nutr 47:171–182
103. Mullally MM, Meisel H, FitzGerald RJ (1997) Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine b-lactoglobulin. FEBS Lett 402:99–101
104. Murakami Y, Hirata A (2000) Novel process for enzymatic hydrolysis of proteins in an aqueous two-phase system for the production of peptide mixture. Prep Biochem Biotechnol 30(1):31–37
105. Murray BA, FitzGerald RJ (2007) Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr Pharm Des 13:773–791
106. Nagao JI, Asaduzzaman SM, Aso Y, Okuda KI, Nakayama J, Sonomoto K (2006) Lantibiotics: insight and foresight for new paradigm. J Biosci Bioeng 102:139–149
107. Nagaoka S, Futamura Y, Miwa K, Takako A, Yamauchi K, Kanamaru Y, Tadashi K, Kuwata T (2001) Identification of novel hypocholesterolemic peptides derived from bovine milk β-lactoglobulin. Biochem Biophys Res Commun 281:11–17
108. Najafian L, Babji AS (2012) A review of fish-derived antioxidant and antimicrobial peptides: their production, assessment and applications. Peptides 33:178–185
109. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T (1995a) Purification and chracterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78:777–783
110. Nakamura Y, Yamamoto N, Sakai K, Takano T (1995b) Antihypertensive effect of sourmilk and peptides isolated from it that are inhibitors to Angiotensin I-converting enzyme. J Dairy Sci 78:1253–1257
111. Nakashima Y, Arihara K, Sasaki A, Ishikawa S, Itoh M (2002) Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 67:434–437
112. Narai-Kanayama A, Shikata Y, Hosono M, Aso K (2010) High level production of bioactive di- and tri-tyrosine peptides by protease-catalysed reactions. J Biotechnol 150:343–347
113. Nurminen ML, Sipola M, Kaarto H, Pihlanto-Leppala A, Piilola K, Korpela R, Tossavainen O, Korhonen H, Vapaatalo H (2000) Alphalactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 66:1535–1543
114. Nyberg F, Sanderson K, Glamsta EL (1997) The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin. Biopolymers 43:147–156
115. Okumura T, Yamada R, Nishimura T (2004) Sourness-supressing peptides in cooked pork loins. Biosci Biotechnol Biochem 68:1657–1662
116. Ondetti MA, Rubin B, Cushman DW (1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Sci 196:441–444
117. Ono T, Takagi Y, Kunishi I (1998) Casein phosphopeptides release from casein micelles by successive digestion with pepsin and trypsin. Biosci Biotechnol Biochem 62:16–21
118. Otte J, Shalaby SM, Zakora M, Pripp AH, El-Shabrawy SA (2007) Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: effect of substrate, enzyme andtime of hydrolysis. Int Dairy J 17:488–503
119. Park KJ, Hyun CK (2002) Antigenotoxic effects of the peptides derived from bovine blood plasma proteins. Enzym Microb Technol 30:633–638
120. Perea A, Ugalde U (1996) Continuous hydrolysis of whey proteins in a membrane recycle reactor. Enzym Microb Technol 18:29–34
121. Petrillo EW Jr, Ondetti MA (1982) Angiotensin converting enzyme inhibitors: medicinal chemistry and biological actions. Med Res Rev 2:1–41
122. Phelan M, Aherne A, FitzGerald RJ, O’Brien NM (2009) Casein-derived bioactive peptides: biological effects, industrial uses, safety aspects and regulatory status. Int Dairy J 19:643–654
123. Pihlanto A (2006) Antioxidative peptides derived from milk proteins. Int Dairy J 16:1306–1314
124. Pihlanto A, Korhonen H (2003) Bioactive peptides and proteins. Adv Food Nutr Res 47:175–276
125. Pihlanto-Leppälä A, Koskinen P, Piilola K, Tupasela T, Korhonen H (2000) Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J Dairy Res 67:53–64
126. Pihlanto-Leppälä A (2001) Bioactive peptides derived from bovine whey proteins: opioid and ACE-inhibitory peptides. Trends Food Sci Technol 11:347–356
127. Qian ZY, Jollès P, Migliore-Samour D, Schoentgen F, Fiat AM (1995) Sheep kappa-casein peptides inhibit platelet aggregation. Biochim Biophys Acta 1244:411–417
128. Quiros A, Ramos M, Muguerza B, Delgado M, Miguel M, Alexaindre A, Recio I (2007) Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. Int Dairy J 17:33–41
129. Regester GO, Smithers GW, Mitchell IR, McIntosh GH, Dionysius DA (1997) Bioactive factors in milk: natural and induced. In: Welch R, Burns D, Davis S, Popay A, Prosser C (eds) Milk composition, production and biotechnology. CAB International, Wallingford, pp 119–132
130. Rival SG, Boeriu CG, Wichers HJ (2001a) Caseins and casein hydrolysates. 2. Antioxidative properties and relevance to lipoxygenase inhibition. J Agric Food Chem 49:295–302
131. Rival SG, Fornaroli S, Boeriu CG, Wichers HJ (2001b) Caseins and casein hydrolysates. Lipoxygenase inhibitory properties. J Agric Food Chem 4:287–294
132. Rossini K, Noren CPZ, Cladera-Olivera F, Brandelli A (2009) Casein peptides with inhibitory activity on lipid oxidation in beef homogenates and mechanically deboned poultry meat. LWT Food Sci Technol 42:862–867
133. Roufik S, Gauthier SF, Turgeon SL (2006) In vitro digestibility of bioactive peptides derived from bovine β-lactoglobulin. Int Dairy J 16:294–302
134. Roy MK, Watanabe Y, Tamai Y (1999) Induction of apoptosis in HL-60 cells by skimmed milk digested with a proteolytic enzyme from the yeast Saccharomyces cerevisiae. J Biosci Bioeng 88:426–432
135. Ryan JT, Ross RP, Bolton D, Fitzgerald GF, Stanton C (2011) Bioactive peptides from muscle sources: meat and fish. Nutrients 3:765–791
136. Rydlo T, Miltz J, Mor A (2006) Eukaryotic antimicrobial peptides: promises and premises in food safety. J Food Sci 71:R125–R135
137. Saïd B, Dominique B (2011) Mineral-binding peptides from food. In: Hettiarachchy NS, Sato K, Marshall MR, Kannan A (eds) Bioactive food proteins and peptides. Applications in human health. CRC Press, Boca Raton, pp 117–130
138. Saiga A, Okumura T, Makihara T, Katsuta S, Shimizu T, Yamada R, Nishimura T (2003) Angiotensin I-converting enzymes inhibitory peptides in a hydrolyzed chicken breast muscle extract. J Agric Food Chem 51:1740–1745
139. Saito T (2008) Antihypertensive peptides derived from bovine casein and whey proteins. In: Bösze Z (ed) Advances in experimental medicine and biology: bioactive components of milk, vol 606. Springer, Newyork, pp 295–317
140. Sakanaka S, Tachibana Y, Ishihara N, Juneja LR (2005) Antioxidant properties of casein calcium peptides and their effects on lipid oxidation in beef homogenates. J Agric Food Chem 53:464–648
141. Sato R, Noguchi T, Naito H (1986) Casein phosphopeptide (CPP) enhances calcium absorption from the ligated segment of rat small intestine. J Nutr Sci Vitaminol 32:67–76
142. Seppo L, Jauhiainen T, Poussa T, Korpela R (2003) A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 77(2):326–330
143. Shahidi F, Zhong Y (2008) Bioactive peptides. J AOAC Int 91(4):914–931
144. Sharma S, Singh R, Rana S (2011) Bioactive peptides: a review. Int J Bioautomation 15(4):223–250
145. Silva SV, Malcata FX (2005) Caseins as source of bioactive peptides. Int Dairy J 15:1–15
146. Singh BP, Vij S, Hati S (2014) Functional significance of bioactive peptides derived from soybean. Peptides 54:171–179
147. Sipola M, Finckenberg P, Korpela R, Vapaatalo H, Nurminen ML (2002) Effect of long-term intake of milk products on blood pressure in hypertensive rats. J Dairy Res 69:103–111
148. Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, Goligorsky MS (1995) Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 270:30290–30293
149. Stiuso P, Caraglia M, De Rosa G, Giordano A (2013) Bioactive peptides in cancer: therapeutic use and delivery strategies. J Amino Acids. doi:10.1155/2013/568953
150. Stuknyte M, De Noni I, Gugliemetti S, Minuzzo M, Mora D (2011) Potential immunomodulatory activity of bovine casein hydrolysates produced after digestion with proteinase of lactic acid bacteria. Int Dairy J 21:763–769
151. Su L, Xu G, Shen J, Tuo Y, Zhang X, Jia S, Chen Z, Su X (2010) Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle. Oncol Rep 23(1):3–9
152. Su X, Dong C, Zhang J, Su L, Wang X, Cui H, Chen Z (2014) Combination therapy of anti-cancer bioactive peptide with Cisplatin decreases chemotherapy dosing and toxicity to improve the quality of life in xenograft nude mice bearing human gastric cancer. Cell Biosci 4:7
153. Suarez-Jimenez G-M, Burgos-Hernandez A, Ezquerra-Brauer J-M (2012) Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals. Mar Drugs 10:963–986
154. Suetsuna R, Ukeda H, Ochi H (2000) Isolation and characterization of free radical scavenging activities of peptides derived from casein. J Nutr Biochem 11:128–131
155. s2-casein. FEBS Lett 531:369–374
156. Teschemacher H (2003) Opioid receptor ligands derived from food proteins. Curr Pharm Des 9:1331–1344
157. Turgeon SL, Gauthier SF (1990) Whey peptide fractions obtained with a two-step ultrafiltration process: production and characterization. J Food Sci 55:106–110
158. Urista MC, Fernández ÁR, Rodriguez FR, Cuenca AA, Jurado TA (2011) Review: production and functionality of active peptides from milk. Food Sci Technol Int 17:293–317
159. Vermeirssen V, Van Camp J, Devos L, Verstraete W (2003) Release of angiotensin I convertingenzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: from batch experiment to semicontinuous model. J Agric Food Chem 51:5680–5687
160. Vermeirssen V, van Camp J, Verstraete W (2004) Bioavailability of angiotensin I-converting enzyme inhibitory peptides. Br J Nutr 92:357–366
161. Visser S, Noorman HJ, Slangeen CJ, Rollema HS (1989) Action of plasmin on bovine β-casein in a membrane reactor. J Dairy Res 56:323–333
162. Wang B, Li L, Chi CF, Ma JH, Luo HY, Xu YF (2013) Purification and characterisation of a novel antioxidant peptide derived from blue mussel (Mytilus edulis) protein hydrolysate. Food Chem 138:1713–1719
163. Wang LL, Xiong YI (2008) Inhibition of oxidant-induced biochemical changes of pork myofibrillar protein by hydrolyzed potato protein. J Food Sci 73:C482–C487
164. Won-Kyo J, Pyo-Jam P, Hee-Guk B, Sung-Hoon M, Se-Kwon K (2005) Preparation of Hoki (Johnius belengeri), bone oligophosphopeptide with a high affinity to calcium by carnivorous intestine crude proteinase. Food Chem 91:333–340
165. Yamamoto M, Maeno M, Takano T (1999) Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J Dairy Sci 82:1388–1393
166. Yamamoto N, Akino A, Takano T (1994) Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci 77:917–922
167. Yamamoto N, Ejiri M, Mizuno S (2003) Biogenic peptides and their potential use. Curr Pharm Des 9:1345–1355
168. Yamazaki Y, Maekawa K (1980) Synthesis of a peptide with delicious taste. Agric Biol Chem 44:93–97
169. Yoshikawa M, Sasaki R, Chiba H (1981) Effect of chemical phosphorylation of bovine casein components on the properties related to casein micelle formation. Agric Biol Chem 45:909–914
170. Yu L, Yang L, An W, Su X (2014) Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells. J Cell Biochem 115(4):697–711
171. Yu PL, van der Linden DS, Sugiarto H, Anderson RC (2010) Antimicrobial peptides isolated from the blood of farm animals. Anim Prod Sci 50:660–669
172. Zambrowicz A, Timmer M, Eckert E, Trziszka T (2013) Evaluation of the ACE-inhibitory activity of egg-white proteins degraded with pepsin. Pol J Food Nutr Sci 63(2):103–108
173. Zhang L, Zhou JLK (2010) Chelating and radical scavenging activities of soy protein hydrolysates prepared from microbial proteases and their effect on meat lipid peroxidation. Bioresour Technol 101:2084–2089
174. Zhang X, Beynen A (1993) Lowering effect of dietary milk-whey protein v. casein on plasma and liver cholesterol concentrations in rats. Br J Nutr 70:139–146
175. Zhao Q, Girreau I, Sannier F, Piot JM (1997) Opioid peptides derived from hemoglobin: hemorphins. Biopolymers 43:75–98
176. Zhao QY, Piot JM, Gautier V, Cottenceau G (1996) Isolation and characterization of a bacterial growth-stimulating peptide from a peptic bovine haemoglobin hydrolysate. Appl Microb Biotechnol 45:778–784
177. Zimecki M, Kruzel ML (2007) Milk-derived proteins and peptides of potential therapeutic and nutritive value. J Exp Ther Oncol 6:89–106